EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antibody response to Plasmodium vivax in the context of Epstein-Barr virus (EBV) co-infection: A 14-year follow-up study in the Amazon rainforest

Luiz F F Guimarães, Bárbara A Rodrigues, Michelle H F Dias, Matheus G Barcelos iD, Maria F A Nascimento, Sâmick L Moreira-Nascimento, Sofia L Afonso, Barbara G S Abreu, Jaap M Middeldorp iD, Francis B Ntumngia, John H Adams iD, Camila Fabbri iD und 4 weitere

PLOS ONE · 29.01.2025 · 20 (1) · e0311704

DOI: 10.1371/journal.pone.0311704 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 29.01.2025. Verfasst von Luiz F F Guimarães und 15 weiteren Autor:innen. Beteiligte Einrichtung: Instituto René Rachou, Fiocruz Minas, Fundação Oswaldo Cruz (Fiocruz), Belo Horizonte, Minas Gerais, Brazil. Hauptthemen laut MEDLINE: Plasmodium vivax, Epstein-Barr Virus Infections, Malaria, Vivax, Herpesvirus 4, Human. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação de Amparo à Pesquisa do Estado de Minas Gerais.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background To develop an effective vaccine against Plasmodium vivax , the most widely dispersed human malaria parasite, it is critical to understand how coinfections with other pathogens could impact malaria-specific immune response. A recent conceptual study proposed that Epstein-Barr virus (EBV), a highly prevalent human herpesvirus that establishes lifelong persistent infection, may influence P . vivax antibody responses. Here, it was investigated whether EBV could impact the longevity of humoral immune response to P . vivax . Methodology/principal findings A 14-year follow-up study was carried out among long-term P . vivax -exposed Amazonian individuals (272, median age 35 years), and included 9 cross-sectional surveys at periods of high and low malaria transmission. The experimental approach focused on monitoring antibodies to the major blood-stage P . vivax vaccine candidate, the Duffy binding protein region II (DBPII-Sal1), including a novel engineered DBPII-based vaccine targeting conserved epitopes (DEKnull-2). In parallel, the status of EBV infection was determined over time by the detection of circulating EBV DNA (EBV-DNAemia) and EBV-specific antibodies to lytic (VCAp18) or latent (EBNA1) antigens. Regardless of the malaria transmission period, the results demonstrated that one or multiple episodes of EBV-DNAemia did not influence the longevity of DBPII immune responses to both strain-specific (Sal-1) or strain-transcending (DEKnull-2) antibodies. Also, the average time in which DBPII-responders lost their antibodies was unrelated to the EBV serostatus. Considering all malaria cases detected during the study, there was a predominance of P . vivax mono-infection (76%), with a positive correlation between malaria infection and EBV-DNAemia. Conclusions/significance In an immunocompetent P . vivax -exposed adult population neither sporadic episodes of EBV-DNAemia nor antibody responses to lytic/latent EBV antigens influence the longevity of both strain-specific and strain-transcending DBPII immune responses. Further studies should investigate the role of acute P . vivax infection in the activation of EBV replication cycle.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plasmodium vivaxEpstein-Barr Virus InfectionsMalaria, VivaxHerpesvirus 4, HumanCoinfectionAntibodies, ProtozoanRainforestAntibody FormationHumansFollow-Up StudiesAdultFemaleMaleMiddle AgedAdolescentYoung AdultCross-Sectional StudiesBrazil

Substanzen

Antibodies, Protozoan

Autor:innen und Institutionen

  • Instituto René Rachou, Fiocruz Minas, Fundação Oswaldo Cruz (Fiocruz), Belo Horizonte, Minas Gerais, Brazil.
  • Departamento de Microbiologia, Laboratório de Vírus, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil.
  • Department of Pathology, Vrije Universiteit Medical Center, Amsterdam, The Netherlands.
  • Center for Global Health and Interdisciplinary Disease Research, College of Public Health, University of South Florida, Tampa, Florida, United States of America.
  • Instituto Leônidas & Maria Deane, Fiocruz Amazônia, Fundação Oswaldo Cruz, Manaus, Amazonas, Brazil.
  • Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Unidade de Pesquisa Clínica Carlos Borborema, Manaus, Amazonas, Brazil.

ORCID-Profile: Matheus G Barcelos, Jaap M Middeldorp, John H Adams, Camila Fabbri, Luzia H Carvalho

Förderung

  • NIAID NIH HHS
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Fundação de Amparo à Pesquisa do Estado de Minas Gerais
  • Fundação Oswaldo Cruz
  • NIH Research Project Grant Program

Zitieren

APA

Guimarães, L. F. F., Rodrigues, B. A., Dias, M. H. F., Barcelos, M. G., Nascimento, M. F. A., Moreira-Nascimento, S. L., Afonso, S. L., Abreu, B. G. S., Middeldorp, J. M., Ntumngia, F. B., Adams, J. H., Fabbri, C., Lopes, S., Fernandes, C. J. F., Kano, F. S., & Carvalho, L. H. (2025). Antibody response to Plasmodium vivax in the context of Epstein-Barr virus (EBV) co-infection: A 14-year follow-up study in the Amazon rainforest. PLOS ONE, 20(1), e0311704. https://doi.org/10.1371/journal.pone.0311704

Vancouver

Guimarães LFF, Rodrigues BA, Dias MHF, Barcelos MG, Nascimento MFA, Moreira-Nascimento SL, et al. Antibody response to Plasmodium vivax in the context of Epstein-Barr virus (EBV) co-infection: A 14-year follow-up study in the Amazon rainforest. PLOS ONE. 2025;20(1):e0311704. doi:10.1371/journal.pone.0311704

BibTeX
@article{Guimares2025,
  author = {Guimarães, Luiz F F and Rodrigues, Bárbara A and Dias, Michelle H F and Barcelos, Matheus G and Nascimento, Maria F A and Moreira-Nascimento, Sâmick L and Afonso, Sofia L and Abreu, Barbara G S and Middeldorp, Jaap M and Ntumngia, Francis B and Adams, John H and Fabbri, Camila and Lopes, Stefanie and Fernandes, Cor J F and Kano, Flora S and Carvalho, Luzia H},
  title = {Antibody response to Plasmodium vivax in the context of Epstein-Barr virus (EBV) co-infection: A 14-year follow-up study in the Amazon rainforest},
  journal = {PLOS ONE},
  year = {2025},
  volume = {20},
  number = {1},
  pages = {e0311704},
  doi = {10.1371/journal.pone.0311704}
}
Kostenlos starten →